Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05357378 · ClinicalTrials.gov registry record · NA
Safety and Effectiveness of the HIT Reverse HRS
A NA study of Osteoarthritis, Hip and Degenerative Joint Disease, sponsored by Hip Innovation Technology.
- Recruiting
- Registry status
- NA
- Development phase
- 288
- Enrollment target
- 6
- Study locations
NCT05357378: Recruiting NA study of Osteoarthritis, Hip and Degenerative Joint Disease, sponsored by Hip Innovation Technology.
NCT05357378 is a NA study of Osteoarthritis, Hip and Degenerative Joint Disease that is actively recruiting participants, run by Hip Innovation Technology. The registered enrollment target is 288 participants, below the 1,259-participant average among 20 other Osteoarthritis, Hip trials with a reported enrollment target (77% lower). The trial reports 6 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05357378, a NA study of Osteoarthritis, Hip and Degenerative Joint Disease, is actively recruiting participants, sponsored by Hip Innovation Technology.
- RECRUITING
- Registry status
- NA
- Development phase
- 288 participants
- Enrollment target
- 6
- Study locations
Study Summary
The purpose of this study is to determine if the use of the HIT Reverse Hip Replacement System is safe and effective in patients undergoing total hip replacement. We will determine whether it is safe and effective by comparing it to the control devices.
Primary Outcome
The Oxford Hip Score (OHS) is a 12-item patient-reported outcome measure designed and developed to assess function and pain in patients undergoing hip replacement surgery. It ranges from 0 (poor) to 48 (best).
Conditions Studied
Interventions
- DEVICE Hip Innovation Technology Reverse Hip Replacement System
- DEVICE Already-marketed semi-constrained uncemented hip systems using a metal-on-XLPE or ceramic-on-XLPE bearing combination.
Study Locations (6)
Florida
- Miami Institute for Joint Reconstruction - Miami
- Advent Health Hospital, Carrollwood - Tampa
- Tampa General Health / Florida Orthopedic Institute - Tampa
Maryland
- LifeBridge Health Rubin Institute for Advanced Orthopedics - Baltimore
New Jersey
- Division of Orthopaedic Surgery - Somers Point
Ohio
- JIS Orthopedics - New Albany
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 288 participants |
| Start Date | 2022-07-15 |
| Est. Completion | 2035-07-15 |
| Phase | NA |
What NCT05357378 shows while recruiting
NCT05357378 is an interventional study that assigns participants to a tested intervention. The registered 288 participants enrollment target is mid-sized for trials with a published cap, below the 1,259-participant average among 20 other Osteoarthritis, Hip trials with a reported enrollment target (77% lower).
The record links to 4 conditions, with Osteoarthritis, Hip appearing as the primary indexed condition, and to 2 interventions - of which Hip Innovation Technology Reverse Hip Replacement System is the first listed.
NCT05357378 lists 6 locations in 4 states (Florida, Maryland, New Jersey).
Frequently Asked Questions
What is clinical trial NCT05357378 about?
NCT05357378 is a clinical study titled "Safety and Effectiveness of the HIT Reverse HRS". The purpose of this study is to determine if the use of the HIT Reverse Hip Replacement System is safe and effective in patients undergoing total hip replacement. We will determine whether it is safe and effective by comparing it to the control devices.
What is the current status of trial NCT05357378?
This trial is currently recruiting. It is a NA study. The enrollment target is 288 participants. The study started on 2022-07-15. Estimated completion is 2035-07-15.
What conditions does trial NCT05357378 study?
This clinical trial studies the following conditions: Osteoarthritis, Hip, Degenerative Joint Disease, Avascular Necrosis of Hip, Traumatic Arthropathy-Hip.
What interventions are being tested in trial NCT05357378?
The interventions under investigation include: Hip Innovation Technology Reverse Hip Replacement System (DEVICE), Already-marketed semi-constrained uncemented hip systems using a metal-on-XLPE or ceramic-on-XLPE bearing combination. (DEVICE).
Who is sponsoring clinical trial NCT05357378?
This trial is sponsored by Hip Innovation Technology, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05357378 being conducted?
This trial has 6 study locations across Florida, Maryland, New Jersey, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoarthritis, Hip
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05357378's enrollment target sits among peer trials
288 8th of 20 higher than 13 of 20 other Osteoarthritis, Hip trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Osteoarthritis, Hip trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Non-invasive Evaluation of Upper and Lower Body Function With Showmotion
RECRUITING · NA
-
G7 Acetabular System With Vivacit-E or Longevity Liner PMCF Study
RECRUITING · NA
-
Outcomes of Low-Impact Exercise Program for People With Ankle, Knee, and/or Hip Pain
RECRUITING · NA
-
Early Feasibility Study of Cartilage Defect Repair
RECRUITING · NA
-
Adipose-Derived Biocellular Regenerative Therapy for Osteoarthritis
RECRUITING · NA
-
Arthroscopic Labral Repair Versus Physical Therapy for Tears of the Acetabular Labrum
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02098265 · 288 participants · NA
A Closed Loop Neural Activity Triggered Stroke Rehabilitation Device
- NCT03741777 · 288 participants · NA
Comparison of Residual Gastric Volume Between Children Who Drink Different Clear Oral Fluid Volume
- NCT03937635 · 288 participants · Phase 3
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
- NCT04621877 · 288 participants · NA
Lay-Delivered Behavioral Activation in Senior Centers
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI